Blunt carotid and vertebral arterial injuries

WL Biffl, EE Moore, PJ Offner… - World journal of …, 2001 - search.proquest.com
Blunt carotid and vertebral arterial injuries are uncommon but have the potential for
devastating consequences. The classic presentation is a neurologic deficit unexplained by …

[图书][B] Essentials of Cardiopulmonary Physical Therapy-E-Book

E Hillegass - 2022 - books.google.com
UPDATED! Content and references throughout present the most current and relevant
information for today's clinical practice. NEW! Two additional chapters on Management of …

The role of platelets in hemostasis and the effects of snake venom toxins on platelet function

MR de Queiroz, BB de Sousa, DF da Cunha Pereira… - Toxicon, 2017 - Elsevier
The human body has a set of physiological processes, known as hemostasis, which keeps
the blood fluid and free of clots in normal vessels; in the case of vascular injury, this process …

Tumor Microenvironment Remodeling‐Mediated Sequential Drug Delivery Potentiates Treatment Efficacy

Y Xu, J Lv, F Liu, J Wang, Y Liu, C Kong, Y Li… - Advanced …, 2024 - Wiley Online Library
Abstract Toll‐like receptor 7/8 agonists, such as imidazoquinolines (IMDQs), are promising
for the de novo priming of antitumor immunity. However, their systemic administration is …

Comparative pharmacology of GP IIb/IIIa antagonists

K Schrör, AA Weber - Journal of thrombosis and thrombolysis, 2003 - Springer
GP IIb/IIIa antagonists are qualitatively different from classical antiplatelet agents, such as
aspirin or clopidogrel. They do not inhibit platelet activation, ie intraplatelet signal generation …

Targeted delivery of therapeutics to endothelium

E Simone, BS Ding, V Muzykantov - Cell and tissue research, 2009 - Springer
The endothelium is a target for therapeutic and diagnostic interventions in a plethora of
human disease conditions including ischemia, inflammation, edema, oxidative stress …

Approaching the golden age of natural product pharmaceuticals from venom libraries: an overview of toxins and toxin-derivatives currently involved in therapeutic or …

JW Fox, SMT Serrano - Current pharmaceutical design, 2007 - ingentaconnect.com
Poisons and the toxins found in venomous and poisonous organisms have been the focus of
much research over the past 70 years, most of which has been directed at understanding the …

Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions

S Goto, N Tamura, S Handa, M Arai, K Kodama… - Circulation, 2002 - Am Heart Assoc
Background—We studied the role of glycoprotein (GP) VI in platelet adhesion and thrombus
formation on the immobilized collagen and von Willebrand factor (vWF) surface under flow …

New antiplatelet drugs and new oral anticoagulants

V Koenig-Oberhuber, M Filipovic - BJA: British Journal of …, 2016 - academic.oup.com
In our daily anaesthetic practice, we are confronted with an increasing number of patients
treated with either antiplatelet or anticoagulant agents. During the last decade, changes …

Routine invasive strategies versus selective invasive strategies for unstable angina and non‐ST elevation myocardial infarction in the stent era

JP Fanning, J Nyong, IA Scott… - Cochrane Database …, 2016 - cochranelibrary.com
Background People with unstable angina and non‐ST elevation myocardial infarction
(UA/NSTEMI) are managed with a combination of medical therapy, invasive angiography …